The Journal of Clinical and Translational Research is an open access, peer-reviewed, multidisciplinary scientific journal that publishes studies with at least an ex vivo, in vivo, or clinical component. The published research is centered on any clearly defined clinical problem, which may comprise a disease or the basis of disease, a form of therapy or intervention, and clinical diagnostics or prognostics. Articles that combine preclinical and clinical data are given priority. Contributions from academic institutions and industry are welcome.

As the world’s largest non-profit funder of Parkinson’s research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson’s disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson’s patients, business leaders, clinical trial participants, donors and volunteers. The Foundation has fundamentally altered the trajectory of progress toward a cure.

The Cure Parkinson’s Trust (CPT) was founded in 2005 by four people living with Parkinson’s. It has one bold aim – to cure the condition. CPT funds innovative projects and inspirational scientists with the aim of building momentum towards a cure. We bring scientists together to improve communication and promote collaboration. We adopt a straightforward ‘no nonsense’ approach to making an impact in the Parkinson’s research arena.

                     PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.

Technology Networks is an internationally recognised, online publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discovery and analytical arenas. Our portfolio of 30 communities are available free of charge on our website.

MassBio is a not-for-profit organization committed to advancing Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Founded in 1985, MassBio represents over 650 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.  

Neural Cell News is a free, weekly e-newsletter that keeps the neural cell research community informed by providing the latest news from all areas of the field, from science, research and business, to regulatory affairs. Subscribe today to stay current in the latest research news.     www.neuralcellnews.com